drugset / Trial / NCT00770770

Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina

NCT00770770

Phase 2 Terminated 20 enrolled Alimera Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will assess the safety and efficacy of FA Intravitreal Inserts in subjects with macular edema secondary to RVO.

Timeline

Start
2009-05
Primary completion
2013-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject fluocinolone acetonide Small molecule 0.2 ug Intravitreal
Subject fluocinolone acetonide Small molecule 0.5 ug Intravitreal